Genvisc 850, inj, 1mg
Products billed under this code include GenVisc 850.
Payment limit per 1 MG, by effective quarter, 3Q22 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under J7320
From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| GenVisc 850 | Avanos Medical Sales, LLC | 50653-0006-01 | 25 | $105.775 |
Every quarter
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $4.231 | +$0.423 | 1 MG | Genvisc 850, inj, 1mg | v1, posted September 17, 2026 |
| 3Q26 | $3.808 | +$0.132 | 1 MG | Genvisc 850, inj, 1mg | v1, posted September 15, 2026 |
| 2Q26 | $3.676 | −$1.083 | 1 MG | Genvisc 850, inj, 1mg | v1, posted September 15, 2026 |
| 1Q26 | $4.759 | −$1.014 | 1 MG | Genvisc 850, inj, 1mg | v1, posted September 15, 2026 |
| 4Q25 | $5.773 | −$0.25 | 1 MG | Genvisc 850, inj, 1mg | v1, posted September 8, 2026 |
| 3Q25 | $6.023 | −$0.291 | 1 MG | Genvisc 850, inj, 1mg | v1, posted March 10, 2026 |
| 2Q25 | $6.314 | +$0.142 | 1 MG | Genvisc 850, inj, 1mg | v1, posted March 10, 2026 |
| 1Q25 | $6.172 | +$0.276 | 1 MG | Genvisc 850, inj, 1mg | v1, posted December 19, 2025 |
| 4Q24 | $5.896 | +$0.771 | 1 MG | Genvisc 850, inj, 1mg | v1, posted June 11, 2025 |
| 3Q24 | $5.125 | −$0.038 | 1 MG | Genvisc 850, inj, 1mg | v1, posted June 11, 2025 |
| 2Q24 | $5.163 | −$0.581 | 1 MG | Genvisc 850, inj, 1mg | v1, posted March 11, 2025 |
| 1Q24 | $5.744 | −$0.031 | 1 MG | Genvisc 850, inj, 1mg | v1, posted December 19, 2024 |
| 4Q23 | $5.775 | −$0.33 | 1 MG | Genvisc 850, inj, 1mg | v1, posted October 10, 2024 |
| 3Q23 | $6.105 | −$0.636 | 1 MG | Genvisc 850, inj, 1mg | v1, posted June 5, 2024 |
| 2Q23 | $6.741 | −$0.571 | 1 MG | Genvisc 850, inj, 1mg | v1, posted February 23, 2024 |
| 1Q23 | $7.312 | +$0.914 | 1 MG | Genvisc 850, inj, 1mg | v1, posted December 6, 2023 |
| 4Q22 | $6.398 | +$0.225 | 1 MG | Genvisc 850, inj, 1mg | v1, posted June 22, 2023 |
| 3Q22 | $6.173 | – | 1 MG | Genvisc 850, inj, 1mg | v1, posted June 9, 2023 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
CMS source files
- 4Q26: 2026-09-17_october-2026-medicare-part-b-payment-limit-files-final.zipposted September 17, 2026
- 4Q26: 2026-09-17_october-2026-ndc-hcpcs-crosswalk-final.zipposted September 17, 2026
- 3Q26: 2026-09-15_july-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 2Q26: 2026-09-15_april-2026-medicare-part-b-payment-limit-files-final-file.zipposted September 15, 2026
- 1Q26: 2026-09-15_january-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 4Q25: 2026-09-08_october-2025-asp-pricing-final-file.zipposted September 8, 2026
- 3Q25: 2026-03-10_july-2025-asp-pricing-file.zipposted March 10, 2026
- 2Q25: 2026-03-10_april-2025-asp-pricing-file.zipposted March 10, 2026
- 1Q25: 2025-12-19_january-2025-asp-pricing-file-03-11-25-final-file.zipposted December 19, 2025
- 4Q24: 2025-06-11_october-2024-asp-pricing-file.zipposted June 11, 2025
- 3Q24: 2025-06-11_july-2024-asp-pricing-file.zipposted June 11, 2025
- 2Q24: 2025-03-11_april-2024-asp-pricing-file.zipposted March 11, 2025
- 1Q24: 2024-12-19_january-2024-asp-pricing-file.zipposted December 19, 2024
- 4Q23: 2024-10-10_october-2023-asp-pricing-file.zipposted October 10, 2024
- 3Q23: 2024-06-05_july-2023-asp-pricing-file.zipposted June 5, 2024
- 2Q23: 2024-02-23_april-2023-asp-pricing-file.zipposted February 23, 2024
- 1Q23: 2023-12-06_january-2023-asp-pricing-file.zipposted December 6, 2023
- 4Q22: 2023-06-22_october-2022-asp-pricing-file.zipposted June 22, 2023
- 3Q22: 2023-06-09_july-2022-asp-pricing-file.zipposted June 9, 2023